An economic evaluation of first-line cryoballoon ablation versus antiarrhythmic drug therapy for the treatment of paroxysmal atrial fibrillation from a German healthcare payer perspective

• Main Authors: Malte Kuniss (Author), Lucy Hillcoat (Author), Joe Moss (Author), Florian Straube (Author), Jason Andrade (Author), Oussama Wazni (Author), Gian Battista Chierchia (Author), Lukas Schwegmann (Author), Eleni Ismyrloglou (Author), Alicia Sale (Author), Stuart Mealing (Author), Tom Bromilow (Author), Emily Lane (Author), Damian Lewis (Author), Andreas Goette (Author)
• Format: Book
• Published: BMC, 2024-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Three recent randomized controlled trials demonstrated that, in patients with symptomatic paroxysmal atrial fibrillation (PAF), first-line pulmonary vein isolation with cryoballoon catheter ablation reduces atrial arrhythmia recurrence compared to initial antiarrhythmic drug (AAD...